CMS Proposes Medicare Coverage For Artificial Hearts Manufactured By Abiomed, SynCardia
Wednesday, February 6th, 2008
Artificial heart manufacturers Abiomed and SynCardia Systems on Monday announced that CMS has proposed to extend Medicare coverage to the devices for beneficiaries who participate in clinical trials approved by FDA, the AP/Boston Herald reports. The proposal opens a 30-day public comment period, with CMS expected to issue a final Medicare coverage decision by May 1.